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AIM
The purpose of this study was to evaluate the usefulness of virtual 
cystoscopy  using  a  volume rendering  algorithm performed  with  multi 
detector CT in patients with urinary bladder tumors   and compare with 
the  standard  conventional  cystoscopy  and  to  determine  the  modality’s 
detection rate and positive predictive value.  And to rule out multi centric 
lesions, metachronous  urothelial  tumors and guiding the urologist with 
number of   lesions  in bladder and help in  pre cystoscopy  and treatment 
planning. 
To   follow the patients with  ( TURBT)  transurethral removal of 
bladder tumor for recurrence and in radical cystectomy   patients  with 
urinary diversion for follow up where rigid endoscopy is not possible.
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INTRODUCTION
Bladder neoplasms
Primary  bladder neoplasms account for 2%–6% of all tumors, with 
bladder cancer ranked as the fourth most common malignancy41. Tumors 
may arise from the epithelial surface or any of the various layers of the 
bladder wall. The most   common   complaints  in  bladder  disease are 
microscopic  and  macroscopic  hematuria,  dysuria  and  other  voiding 
symptoms. Over 80% of patients   with   bladder cancer have hematuria, 
which is typically macroscopic and painless.42 Patients presenting with 
macroscopic hematuria should undergo thorough evaluation to determine 
the cause43.
Microscopic hematuria,  defined as three or more red blood cells 
per high-power field from two of three urine specimens,  is  usually an 
incidental  finding.  According  to  the  American  Urological  Association 
guidelines, patients with asymptomatic microscopic hematuria who have 
no evidence of primary renal disease and in whom benign causes such as 
menstruation, exercise, trauma, and infection have been excluded require 
urologic  work-up.44 The  guidelines  recommend  upper  tract  imaging 
evaluation with computed tomography (CT) or excretory urography and 
bladder evaluation with cystoscopy.44
Patients may also experience voiding symptoms such as frequency, 
dysuria, and pelvic pain and pressure.  All these symptoms may   also be 
related to inflammatory, stones, neurologic, obstructive or congenital 
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abnormalities. Urogram,  sonography (US), computed tomography 
(CT),  magnetic  resonant  imaging  (MRI)  and  some  other  radiological 
modality  have  been  used  for  a  long  time  in  all  these  pathologies.44 
However, conventional cystoscopy is a standard diagnostic approach for 
urinary  bladder  evaluation,  its  primary  indication  is  the  diagnosis  of 
lower urinary tract disease, signs, and symptoms that may be related to 
the  urinary  tract  are  evaluated  using  cystoscopy  to  directly  visualize 
lower urinary tract anatomy and macroscopic pathology. However, this 
procedure has drawbacks,  including its  high costs and an invasiveness 
that may lead to iatrogenic bladder injury and urinary sepsis.30 
CT is  usually  recommended as a  useful  radiologic  approach for 
assessing  bladder  disease,  but  CT has  low sensitivity  for  detection  of 
small bladder lesions. For CT to depict a small bladder lesion, optimal 
imaging   conditions adequate bladder distention and thin-slice scanning 
must  be  satisfied.42 Therefore,  negative  findings  on  CT  warrant 
performance  of  conventional  cystoscopy  in  patients  with  bladder 
pathology  .Recently,  three-dimensional  computer-rendering  techniques 
with  rapid  image  acquisition  have  led  to  the  development  of  virtual-
reality  imaging.22 With commercially  available software,  virtual reality 
imaging allows  interactive  intraluminal navigation through the bladder 
simulating conventional cystoscopy and   ureters all the way  up to  the 
pelvi-calyceal  system.  This  can  be  performed  as  part  of  a  routine 
contrast-enhanced  abdominal CT  examination  or  as  part  of  CT 
urography.44
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ANATOMY
The  bladder wall  consists of four layers.  The lumen is lined by 
uroepithelium, which consists of three to seven layers of stratified flat 
cells. The more superficial layers contain large cells with large nuclei and 
acidophilic cytoplasm and small amounts of neutral mucin. These cells 
are  flexible  and  can  change  shape  from cuboidal  to  flattened  as  the 
bladder distends, hence the term transitional epithelium. 
The second layer underneath the epithelium is the lamina propria, 
which is  very  vascular.  Deep to  the  lamina propria  is  the third layer, 
consisting of  bundles of  smooth detrusor  muscle  (muscularis  propria). 
The detrusor muscle is a complex network of interlacing smooth muscle 
fibers.  The  inner  and  outer  muscle  fibers  tend  to  be  oriented  in  a 
longitudinal fashion, but distinct layers are usually not discernible. Fibers 
from the  detrusor  muscle  merge  with  the  prostate  capsule  or  anterior 
vagina and pelvic floor muscles.
A fourth adventitial layer is formed by connective tissue. A serosal 
covering,  formed by  the  peritoneum,  is  present  only  over  the  bladder 
dome. The bladder is within the extra peritoneal space and is surrounded 
by pelvic fat.
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PATHOLOGY OF BLADDER NEOPLASMS
Primary  bladder neoplasms  account  for  2%–6%  of  all  tumors 
bladder cancer ranked as the fourth most common malignancy.  Tumors 
may arise from the epithelial surface or any of the various layers of the 
bladder wall. Bladder cancer is more common in men than in women, 
with a male-to-female ratio of 3–4:147 however, in women it is diagnosed 
at a more advanced stage and has a higher mortality rate than in men. 
Although urothelial cancer is less than half as common in black men, they 
have a higher mortality rate than white men. However, the 5-year survival 
rate currently at 82% over all.45
They  are  broadly  classified  as  either  epithelial  or  nonepithelial 
(mesenchymal), with over 95% being epithelial .Epithelial  tumors with 
differentiation toward normal urothelium are urothelial.47
Epithelial tumors
Urothelial tumors 
benign papilloma through carcinoma; in situ to invasive carcinoma 
squamous carcinoma and adenocarcinoma. 
Much rarer epithelial  tumors are small cell/neuroendocrine carcinoma, 
carcinoid, and melanoma.
9
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Neoplasms derived from mesenchymal tissue differentiate toward 
muscle, nerve, cartilage, fat, fibrous tissue, and blood vessels. 
Benign tumors Malignant tumors
Leiomyoma,  paraganglioma,
 fibroma,  plasmacytoma,
aaa hemangioma,  neurofibroma,
solitary fibrous tumor, and lipoma.
rhabdomyosarcoma,
 leiomyosarcoma, 
lymphoma, osteosarcoma
Urothelial Carcinoma
Urothelial  (transitional  cell)  cancer  is  the most  common  urinary 
tract cancer.  Both the incidence and mortality increase with advancing 
age.  After  the  age  of  80  years,  bladder cancer  is  twice  as  likely  to 
develop.  Urothelial carcinoma has a propensity to be multi centric with 
synchronous and metachronous bladder and upper tract tumors41.  Multi 
centric bladder tumors occur in up to 30%–40% of cases41,52. Upper tract 
tumors occur in 2.6%–4.5% of bladder tumor cases and are seen most 
frequently when multiple bladder lesions are present53,54.
Pathogenesis for urothelial tumor
Direct  prolonged contact  of  the  bladder urothelium   with urine 
containing excreted carcinogens, predominantly from cigarette smoking. 
Smokers have four times the risk of bladder cancer, related to both the 
duration  and  amount  of  smoking.47 There  is  also  a  well-
documented  causal  link  between  urothelial  cancer  and  a  variety  of 
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occupational  and  environmental  chemicals,  including  beta-
naphthylamines,  bladder stones, chronic infection and irritation, as well 
as  drugs  such  as  phenacetin  and  cyclophosphamide,  and  arsenic  in 
drinking water.  Occupational exposure to hair dyes is  also believed to 
increase  the  risk  of  bladder cancer,  but  not  the  personal  use.42,48,  49. 
Bladder diverticula  have  an  increased  risk  (2%–10%)  of  developing 
cancer  because  of  stasis.41 urothelial  cancer  is  the  most  common 
neoplasm  in  bladder diverticula.  They  can  be  papillary,  sessile,  or 
nodular.  Sessile  lesions  include  reactive  urothelial  hyperplasia,  atypia, 
dysplasia, and carcinoma in situ50.  Carcinoma in situ is a non invasive 
high-grade  lesion47 with  significant   anaplastic  change  within  the 
urothelium and  cytologically malignant cells .It accounts for 1%–3% of 
urothelial  neoplasms  and may  progress  to  invasive  carcinoma.  Sessile 
lesions  are  more  likely  to  invade  muscle.  However,  the  prognosis 
correlates more with tumor grade than with morphology (ie, papillary vs 
flat). Most invasive tumors are high-grade carcinoma.47
75% of patients have superficial papillary  tumors, which have a 
“frond-like” appearance at  cystoscopy .The majority have a prolonged 
clinical course with multiple recurrences responding to local resection, 
without progression to malignancy. 20%of  tumors are aggressive43 and 
invasive de novo, and 10% are metastatic at presentation. 
s
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Papillary  lesions  are  papilloma,  inverted  papilloma,  papillary 
urothelial  neoplasm of low malignant  potential  (PUNLMP),  low-grade 
and high-grade papillary  urothelial  carcinoma42.  PUNLMP   is  a  low-
grade,  small,  solitary  neoplasm  that  neither  invades  nor  metastasizes 
.Distinction from low-grade carcinoma may be difficult and subjective. 
Since approximately 35% of PUNLMPs recur and 11% progress in grade, 
surveillance is required50.
 Pathologic stage is the most important predictor of survival42 The 
TNM classification  from the  American  Joint  Committee  on  Cancer,  a 
modification of the Jewett-Strong staging system, is in widespread use55. 
Superficial bladder cancer is confined to the mucosa and lamina propria. 
Once  extension  occurs  into  the  detrusor  muscle  layer,  the  tumor  is 
considered  invasive.  Invasion  may  progress  to  involve  local  organs 
including  the  prostate,  vagina,  uterus,  and  pelvic  wall.  Tumors 
metastasize  most  commonly  to  pelvic  lymph  nodes,  then  distant 
metastases  occur  in  the  lung,  liver,  and  bone  in  decreasing  order  of 
frequency. 
Jewett-Strong and TNM Staging Systems for Bladder Cancer
Tumors are considered superficial if they do not extend beyond the 
lamina propria (T1 or less). Once the muscle layer (muscularis propria) 
has been invaded (T2a or greater), the tumor is considered invasive.55
G
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Jewett strong urinary bladder tumor staging
        T N M staging            TNM Histo pathological        
0         TO   NO TUMOR 
0         Tis                          carcinoma in situ
0                   TS  papillary tumor  confined to mucosa
A               T1                           tumor invades lamina propria 
BI              T2a                         tumor invades superficial muscle
B2                T2b                         tumor invades deep muscle
B2        T3a    tumor with microscopic peri vesical 
fat Invasion         
C T3b   tumor with macroscopic peri vesical 
fat invasion
D1                T4a   tumor invades surrounding organs
D1                T4b  tumor invades pelvic or abdominal wall
D1                N1-3 pelvic lymph node metastasis
D2 M1   distant metastasis
D2  N4     lymph node metastasis above bifurcation    
Treatment of urothelial carcinoma
 Depends  on  the stage and grade. Superficial  tumors are treated 
with cystoscopic resection followed by close monitoring for recurrences.
Recurrent  tumors are  treated  with  intravesical  agents  such  as 
mitomycin C or bacillus Calmette-Guérin.40         
R
Transurethral resection (TUR) for bladder cancer
It  is  a  surgical  procedure  that  is  used  both  to  diagnose bladder 
cancer and to remove cancerous tissue from the bladder. This procedure 
is also called a TURBT (transurethral resection for bladder tumor).40
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TUR is the most common and effective treatment for early-stage 
superficial bladder cancer.  It  may also be effective for more advanced 
cancer if all the cancer is removed and biopsies show that no cancer cells 
remain. About 70% of people with early-stage and low-grade superficial 
bladder cancer can be effectively treated with a TUR40. 
Radical cystectomy and urinary diversion are reserved for invasive 
cancer.
Systemic chemotherapy is used for local recurrence after surgery or 
to palliate metastases40
Prognosis
Survival is  directly related to depth of invasion and presence of 
metastatic disease.
 If the tumor is confined to the lamina propria, 5-year survival after 
cystectomy is 55%–80%51
v
The 5-year survival drops to 40% with invasion of the muscularis 
propria.51
The 5-year survival drops  to 20% when there is invasion of peri 
vesical fat.
 The 5-year survival rate for metastatic cancer is 6%.41,51
Imaging plays a limited role in long-term surveillance. Radiation, 
fibrosis, and intravesical local therapy may cause wall thickening, which 
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is difficult to distinguish from tumor. Cystoscopy with biopsy remains the 
standard of reference for detecting recurrence but is both invasive and 
expensive, especially since surveillance should be lifelong.54
Urinary cytology is noninvasive and relatively inexpensive and has 
been used for  both tumor detection and long-term surveillance.  It  has 
high  specificity  (94%–99%),  but  the  lack  of  sensitivity  for  low-grade 
tumors (0%–50%)65,66
Squamous Cell Carcinoma
Squamous  cell  carcinoma accounts  for  less  than  5% of  bladder 
neoplasms41.  However where schistosomiasis  (bilharziasis) is  endemic 
accounting for over 50% of bladder cancers69. Patients with non bilharzial 
squamous  bladder carcinoma tend to present after the age of 60 years, 
with a slight male predominance, whereas those with bilharziasis tend to 
be younger and are five times more likely to be male. High  grade 
and  locally  aggressive  with  muscle  invasion  in  80%  .There  is  a 
predilection for the trigone and lateral bladder, At cystoscopy, squamous 
carcinoma  is  a  large,  often  ulcerated,  infiltrating  mass.  In  contrast  to 
urothelial carcinoma, squamous carcinoma is sessile rather than papillary, 
and pure intraluminal growth is not seen .Muscle invasion is present in 
80%71 of  cases  and  extravesical  spread  may  be  extensive,  involving 
surrounding organs and the abdominal wall74. The overall prognosis for 
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squamous cell carcinoma is generally poor. Metastases   found in only 
8%–10% of cases.
Aggressive local treatment with radical cystectomy is the treatment 
of choice69
Adeno carcinoma  
Adeno carcinoma is an uncommon bladder neoplasm representing 
less than 2% of bladder neoplasms.41. (It can be sub classified as primary 
(two-thirds  are  non  urachal  and  one-third  urachal)  or  secondary 
(metastases).
Non urachal urachal cancer
The  mean  age  at 
presentation
M;f
60 years
3:1
50yrs
1:1
r
Adeno  carcinoma  is  classically     associated    with  bladder 
exstrophy, persistent urachus, intestinal metaplasia from chronic mucosal 
irritation,  urinary diversions  such  as  entero  cystoplasty,  in  pelvic 
lipomatosis because of associated cystitis glandularis. Metastatic adeno 
carcinoma to the bladder is more common than primary Adeno carcinoma 
and occurs in a wider age range77. Adenocarcinoma is the most common 
histologic  type  of  secondary  bladder neoplasms.  The  bladder can  be 
directly  invaded by adjacent  pelvic neoplasms,  most  commonly in the 
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colon, prostate, and Rectum77 . It is extremely important to distinguish 
primary from secondary Adeno carcinoma because of different treatment 
options77. As bladder metastases are a late manifestation of cancer, there 
is usually evidence of a locally invasive adjacent primary neoplasm or 
other signs of a distant primary neoplasm
 At  cystoscopy,  primary  Adeno  carcinoma  is  typically  a  single 
nodular lesion77 with 58%–67% favoring the  bladder base and the rest 
located in the region of the urachus. It may be difficult, even with special 
stains,  to  distinguish  primary  adenocarcinoma  from metastases  to  the 
bladder77.
Urachal adenocarcinoma is characteristically located at the dome 
of the bladder in the midline or slightly off midline76. Ninety percent of 
masses occur close to the bladder, with the remainder along the course of 
the urachus or at the umbilical end. It has prominent extra vesical 
component, large, with a mean size of 6 cm80.
At CT, the tumor is mixed solid and cystic in 84% of cases and 
solid in the remainder. The cystic contents  represent  mucin, a common 
finding in these tumors. Calcification present in 72% of cases and is more 
commonly peripheral than stippled80,81.  Urachal  carcinoma can be intra 
luminal, but the bulk of tumor is outside the bladder in 88% of cases80.
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In addition, owing to their extra vesical location, urachal  tumors 
may be clinically silent until quite large, resulting in late presentation and 
poor prognosis80,81,41.
Radical  cystectomy  is  considered  the  treatment  of  choice  for 
primary  adenocarcinoma.  Urachal   adenocarcinoma,  more  aggressive 
surgery including cystectomy and en bloc resection of the urachal mass, 
posterior rectus fascia, peritoneum, and abdominal wall is the standard of 
care.  In contradistinction to urothelial carcinoma, extravesical spread is 
very common, with bladder wall invasion in 92% of cases and metastases 
in 48%80,82. Rarely, pseudo myxoma peritonei may result from peritoneal 
carcinomatosis.
Outcome is poor for invasive  tumors, with an overall 20%–40% 
survival at 5 years83. 
C
Small Cell or Neuroendocrine Tumor
Small  cell  bladder tumor  is  rare,  less  than  0.5%  of  bladder 
neoplasms. They are highly aggressive  tumors, with invasive disease in 
94% at presentation41,84,85. The reported age range is wide, occurring in 
patients from 20 to 91 years, with a male-to-female ratio of 3–5:185.
Small cell  bladder tumors from dedifferentiated neuron endocrine 
cells.  Tumors are typically large and polypoid or nodular and may have 
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an  ulcerated  surface.  The  lateral  bladder walls  are  the  most  common 
site85. Wall invasion is typical, with masses ranging from 3 to 8 cm84. 
Central necrosis and cystic change may be seen with CT85,86. Small 
cell tumors may exhibit very rapid growth .Aggressive behavior is further 
reflected in extensive local invasion.Diffuse peritoneal metastases, lymph 
node metastases occur in 66% of cases86.
Treatment 
Radical   cystectomy and extended pelvic lymph adenectomy88.
Surgical resection alone is unlikely to be curative, unless the tumor 
is  confined to  the  bladder.  Combination therapy with adjuvant  or  neo 
adjuvant  chemotherapy  appears  beneficial(84,88)  .Despite  therapy,  the 
long-term prognosis is poor, with a 16% 5-year survival84,88.
B
Carcinoid
Primary carcinoid tumors are an extremely rare variant 
of neuro endocrine tumors and may be pure or mixed. These 
tumors are round or polypoid and small, with a mean size of 6 
mm. Most are located in the bladder neck or trigone and are 
covered  by  normal  epithelium.89,90.   Behavior  is  typically 
benign, but metastases can occur in up to 30% of cases89.
Leiomyoma
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Leiomyoma  is  the  most  common  mesenchymal  tumor  of  the 
bladder but  accounts  for  only 0.43% of  bladder tumors.91 Leiomyoma 
occur equally in men and women with a wide age range of 22–78 years92. 
Most  are  small  and  asymptomatic  and  are  discovered  incidentally. 
Histologically,  leiomyomas  are  noninfiltrative  smooth  muscle  tumors 
lacking mitotic activity, cellular atypia, and necrosis. Leiomyoma arise in 
the  sub  mucosa,  but  growth  may  be  sub  mucosal  (7%),  intravesical 
(63%), or extravesical (30%)93,94.
At  cystoscopy,  normal  bladder mucosa  covers  the  Leiomyoma. 
Imaging features include either a smooth indentation of the bladder wall 
or an intra luminal mass. They are smooth, solid, homogeneous masses. 
I
Leiomyoma  exhibit intermediate signal intensity on T1-weighted 
images  and  low signal  intensity  on  T2-weighted  images  .Degenerated 
leiomyomas have more heterogeneous signal characteristics95.These are 
benign tumors 
Focal excision of the mass is the treatment of choice. 
Leiomyosarcoma
Leiomyosarcoma  is  the  most  common  non  epithelial  malignant 
bladder tumor in adults92. An increased prevalence is seen after radiation 
therapy  or  systemic  chemotherapy  with  cyclophosphamide  for  another 
neoplasm94.
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Patients present relatively early secondary to hematuria, and many 
have  urinary obstruction. The age range is wide at 25–88 years with a 
male-to-female ratio of 3:192. Eighty percent of leiomyosarcoma are high 
grade at presentation, although both high-grade and low-grade tumors can 
behave aggressively with local recurrence and distant metastases. 
It can be difficult to distinguish Leiomyoma from leiomyosarcoma 
at imaging. Both can have relatively low signal intensity on T2-weighted 
MR images .However, necrosis is common in leiomyosarcoma96 which 
tend to be poorly circumscribed, invasive masses with a mean size of 7 
cm92,96.Consequently, they are more heterogeneous on T2-weighted 
images 
Rhabdomyosarcoma 
Rhabdomyosarcoma is the most common bladder tumor in patients 
under the age of 10 years, with a mean patient age of 4 years99. It affects 
boys more than girls in a ratio of 3:199. It is exceedingly rare in adults. 
Rhabdomyosarcoma can manifest as a diffusely infiltrative lesion or as 
masses, which can be polypoid and “grapelike” (sarcoma botryoides)98. 
There  has  been  a  shift  in  treatment  from  surgical  resection  to 
chemotherapy. With  first-line chemotherapy, the need for radical surgery 
has decreased and the survival rate is greater than 70%.99,100.
Neurofibroma
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Neurofibromas of the bladder are rare, but the bladder is the most 
common genitourinary site of a neurofibroma. They may be isolated or 
occur in association with neurofibromatosis type 1 (von Recklinghausen 
disease,). Neurofibromas arise from the nerve plexuses, which enter near 
the  bladder trigone101.Neurofibromas  may  be  localized,  diffuse,  or 
plexiform.  Plexiform neurofibromas consist  of  nodules.  These  nodules 
may dramatically thicken the  bladder wall, obstruct the ureteral orifice, 
and cause hydronephrosis103. The mass may also bulge into the  bladder 
lumen. In addition, the tumor may involve the uterus, vagina, and urethra 
in  females,  and  the  prostate,  seminal  vesicles,  and  urethra  in 
male101,103.  Large  tumors may  surround  the  rectum and  extend  to  the 
perineum. Masses are typically low in attenuation at CT. Target   sign on 
T2-weighted  images,  which  consists  of  low-signal-intensity  fibrosis 
surrounded by high-signal-intensity myxoid  stroma.104
Paraganglioma
Paragangliomas  may  rarely  manifest  as  a  bladder mass.  They 
account  for  0.1%  of  all  bladder tumors and  1%  of  all 
pheochromocytomas41. The age range is wide at 10–78 years, and there is 
a  female  preponderance.  A  characteristic  clinical  syndrome  of 
catecholamine release during micturition, micturition attack,” occurs in 
50%  of  patients.Paraganglioma  arises  in  the  chromaffin  cells  of  the 
sympathetic chain in the detrusor muscle layer and may occur anywhere 
in  the  bladder96.  At cystoscopy, the findings are  a small,  solitary,  sub 
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mucosal mass or nodule. Biopsy may cause release of catecholamine’s 
and hypertensive crisis. 
CT
A  bladder Para  ganglioma  is  usually  a  solid,  homogeneous, 
lobulated,  well-marginated  mass,  but  cystic  areas  may  result  from 
necrosis  or  hemorrhage105.  A  sub  mucosal  location  at  cross-sectional 
imaging and marked enhancement with either iodinated contrast material 
or  gadolinium  chelates  are  key  features108.  Ring  calcification 
around the circumference of the mass is highly suggestive of a  bladder 
paraganglioma107.
MRI
They are typically of low signal intensity on T1-weighted images 
and moderately high signal intensity on T2-weighted images108.
Iodine 131 metaiodobenzylguanidine (MIBG) scanning is highly 
specific  (96%)  for  paragangliomas.  However,  MR  imaging  is  more 
sensitive  than  either  131I-MIBG  scanning  or  CT109.  PET  with  6-[18F] 
fluorodopamine (an analogue of dopamine) may be superior  to MIBG 
scanning in identifying metastatic lymph node110.
Treatment  consists  of  local  excision  following  adrenergic 
blockade, with lymph adenectomy if the lesion is invasive. Because there 
25
are no reliable histologic criteria to distinguish benign from malignant 
tumors, long-term follow-up is advisable. 
Lymphoma
Primary bladder lymphoma is rare, as there is no lymphoid tissue 
in the bladder, but secondary involvement of the bladder may be present 
in 10%–25% of patients with lymphoma and leukemia .It is most 
common in middle-aged women111.
At cystoscopy or imaging, there are well-defined bladder masses at 
the dome or lateral walls rather than diffuse infiltration111.  The masses 
may mimic urothelial carcinoma. The prognosis is good as most  tumors 
are low grade. Treatment can be with chemotherapy or local radiation 
therapy88.
Bladder   hemangioma 
Can occur at any age, but half manifest in childhood, in adults, the 
mean age is 58 years (range, 19–76 years). And  they are more common 
in males in a ratio of 3.7:1112. Hemangioma may either occur in isolation 
or be associated with syndromes such as Clipped-Trénaunay-Weber or 
Sturge-Weber113.  Tumors were  small,  with  a  median  size  of  0.7  cm 
(range,  0.2–3  cm)112.  Most  were  single,  broad-based,  sessile  bladder 
masses on the postero lateral walls. The finding of a lobulated bluish red 
lesion  at  cystoscopy  is  highly  suggestive112.  Either  a  focal,  lobular, 
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intramural mass or diffuse bladder wall thickening may be observed. The 
tumor has low to intermediate signal  intensity  on T1-weighted images 
and markedly high signal intensity on T2-weighted images107. Increased 
activity  at  blood  pool  scintigraphy  is  highly  suggestive113.  Cavernous 
hemangioma is the most common type, accounting for 78% of 
cases.Hemangioma run a benign course and are treated by biopsy 
with fulguration when small or by partial cystectomy. 
Solitary Fibrous Tumor
Solitary fibrous tumors are exceedingly rare mesenchymal  tumors 
with fibroblastic  differentiation.  When small,  they may be detected as 
incidental  findings.  Larger  tumors manifest  with  urinary frequency  or 
pressure effects. More common in men, they occur in the age group of 
42–67 years)114. At gross pathologic evaluation, they have a tan, whorled, 
fibrotic surface resembling a Leiomyoma. Immune histochemical stains 
are  diagnostic.  At  CT  and  MR  imaging,  these  are  solid  enhancing 
masses115.They  are  typically  of  low  signal  intensity  on  T2-weighted 
images, with larger lesions exhibiting some variability. They are treated 
surgically and do not recur after partial cystectomy41.
u
DIAGNOSIS
27
The standard imaging work-up for gross hematuria and suspected 
urothelial tumor has shifted from excretory urography to cross-sectional 
modalities  such as ultrasonography (US),  CT, and magnetic resonance 
(MR) imaging. Cystoscopy and biopsy are the standard of reference for 
bladder evaluation,  but  imaging  is  important  for  accurate  staging  and 
treatment planning42.
Superficial tumors may not be evident with any imaging study and 
are not staged radiologically. However, with invasive urothelial  tumors, 
detection of pelvic side wall invasion or lymph adenopathy is critical, as 
clinical  staging is  inaccurate.  Furthermore,  complete  evaluation of  the 
urothelial  tract  (both  upper  and  lower)  is  indicated  because  of  the 
propensity for multi centric disease. 
US may be used for initial evaluation of hematuria but is rarely the 
definitive  test.  Lesions  may  be  missed  without  adequate  bladder 
distention, especially small, flat tumors.73
CT  demonstrates  tumoral  calcification  in  approximately  5%  of 
cases47. The  calcification typically encrusts the surface of the tumor and 
may be nodular or arched.  Bladder tumors enhance early approximately 
60 seconds from injection, and may be readily detected with multi 
detector CT73 . With  progression of disease, wall thickening may 
become diffuse. The presence of ureteral obstruction strongly suggests 
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the presence of muscle invasion. Once the tumor has extended into the 
peri vesical fat, increased attenuation or infiltration is noted in the fat73.
Virtual CT cystoscopy, performed with carbon dioxide, room air, 
or contrast material distention of the urinary bladder, has been proposed 
as  a  noninvasive  alternative  to  conventional  cystoscopy22.  Virtual CT 
cystoscopy of a contrast material–filled bladder  can be performed as part 
of a routine contrast-enhanced abdominal CT examination or as part of 
CT urography, enabling   thorough evaluation of the entire urinary tract 
the data were downloaded to an independent workstation equipped with 
software (Navigator; for interactive intra luminal navigation22.
MR imaging
The high intrinsic contrast of MR imaging permits distinction of 
bladder wall layers On T1-weighted images, urine is dark; the  bladder 
wall  and tumor are intermediate in signal intensity48.  As fat is  high in 
signal intensity, T1-weighted sequences are optimal for detection of extra 
vesical infiltration, nodes, and bone metastases.
 Tumor is intermediate in signal intensity on T2-weighted images, 
contrasting with the high signal intensity of urine and low signal intensity 
.
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of muscle  .T2-weighted sequences are  optimal  for  evaluation of 
tumor depth and differentiating tumor from fibrosis and for detection of 
invasion of surrounding organs and marrow metastases48.
With  fast  dynamic  contrast-enhanced  imaging,  bladder cancer 
enhances  more  avidly  and  earlier  than  other  tissues  such  as  normal 
bladder and post biopsy changes53,54,59.This may enable differentiation of 
tumor from fibrosis or edema, although this is still  difficult  soon after 
transurethral resection. MR imaging has a reported staging accuracy of 
72%–96% for the primary tumor and is superior to CT for differentiation 
of superficial versus deep muscle invasion58,60.
MR  detection  of  pathologic  lymph  nodes  (sensitivity,  96%; 
specificity, 95%; and negative predictive value, 98%) has been achieved 
with  an  intravenous  suspension  of  ultra  small  iron  particles, 
ferumoxtran-1061.  Ferumoxtran  is  taken  up  by  macrophages  in  lymph 
nodes and causes loss of signal in normal nodes on T2*-weighted images. 
In  metastatic  nodes,  tumor  replaces  normal  macrophages,  preventing 
uptake of the iron particles and maintaining high nodal signal intensity. 
Distant metastases may be evaluated with either MR imaging or CT 
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Positron emission tomography (PET)
The usefulness of fluorine 18 fluoro deoxyglucose (FDG) positron 
emission tomography (PET) in bladder cancer is limited by the excretion 
of radioisotope into the bladder, which obscures the tumor. Irrigating the 
bladder with saline  improves detection of  bladder tumors62.  Currently, 
optimal  use  of  PET or  PET-CT is  for  detection  of  distant  metastasis, 
pelvic  lymph  node  metastasis,  or  pelvic  recurrence  and  potentially  to 
separate tumor from fibrosis or radiation change63.
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REVIEW OF LITERATURE
KIM  et al22  said that in  a Study   done in Thirty-three patients 
with  contrast  material-filled  bladders  with  single-detector  helical  CT. 
Virtual cystoscopy  has  sensitivity  94%,  specificity  90%,  positive 
predictive value 87%, negative predictive value 93%, and accuracy 93%. 
They   concluded   as  CT  virtual cystoscopy is a noninvasive technique 
that can be used successfully for detection of bladder tumors >5mm 
2.  Constantine Tsampoulas  et al,24 Evaluated   Fifty patients CT 
pneumo cystoscopy. All patients were examined in the supine and prone 
positions after bladder distention with  room air. Fifty-five (96%) of 57 
urinary  bladder  lesions  recognized  at  conventional  cystoscopy  were 
detected with MDCT cystoscopy , including 18 lesions with a diameter of 
.5   cm or less. Transverse, multiplanar reformatted, and virtual images 
proved complementary for lesion detection. They concluded as MDCT 
cystoscopy is an accurate  technique for the detection of urinary bladder 
neoplasm of  lesions smaller than .5 cm. 
3.  D Masulović, et  al25 17 patients has undergone CT virtual and 
conventional  cystoscopy. Two tumors of bladder vault that were  missed 
on transversal  scan  were  visualized  by  virtual  cystoscopy. One tumor 
inside  the  bladder  diverticulum  was  detected,  that  was  not  seen  by 
conventional cystoscopy. In two patients, endoluminal origin  of mass 
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that could not be confirmed by conventional radiologic  methods 
was determined.  They   concluded as  CT virtual  cystoscopy is  useful 
method  a) follow up of bladder tumors; b) supplemental estimation of   
endoscopically  hardly  accessible  regions;  c)  differential  diagnosis 
between intravesical and exravesical lesions. 
4. Yazgan   et al  26 Forty-nine of 54 bladder lesions detected with 
conventional cystoscopy were also shown on virtual  images, three of the 
seven  lesions  5  mm  or  smaller  in  diameter  could  be  identified.  The 
sensitivity of the technique was 96.2% for polypoid tumors and 88.9% for 
sessile lesions. When axial   and virtual images were evaluated together, 
the  sensitivity  rate  increased  to  94.4%.  They  concluded  as  Bladder 
tumors  can  be  diagnosed  noninvasively  using   contrast  medium-filled 
virtual cystoscopy.
5. 27Air   filled and virtual cystoscopy (VC) with 64-channel 
multi  detector  row  CT  (MDCT)  scanner  in  Fifty-nine  patients.  They 
concluded as VC with 64-channel MDCT scanner was very accurate at 
identifying masses larger than 0.5 cm and can show mass as small as 1.4 
mm. Bladder tumors can be diagnosed less-invasively using air filled VC. 
However,  in  the  case  with  severe  bladder  trabeculation  or  wall 
thickening, recommend conventional cystoscopy rather than VC.
.
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 6. Regine et al27 VC demonstrated a good sensitivity for evaluating 
pedunculated  lesions,  allowing  evaluation  of  the  bladder  base  and 
anterior wall, sites that are commonly poorly accessible at conventional 
cystoscopy.  They  concluded  as  Virtual  CT-pneumocystoscopy  can 
replace conventional cystoscopy in cases with pedunculated lesions when 
there is no need for biopsy, Virtual pneumocystoscopy can also be used 
in the follow-up of treated polypoid lesions in association with pelvic CT-
angiography.
7.  Merkle EM,  et al.,33 said that All tumors of the urinary 
bladder identified at fiber optic cystoscopy were also visualized by 
virtual cystoscopy. The best reconstruction results were obtained 
from data acquired after the 30-minute latency period. 
8. Gualdi GF,  et al28 90% of detected on conventional cystoscopy 
were visualized with virtual cystoscopy. Although only a subjective 
evaluation of lesion size was possible on conventional cystoscopy, 
there seemed to be good agreement on mass size and site with 
both techniques. They   concluded as virtual cystoscopy depicted 
all the masses > 1 cm, and a lesion in a diverticulum with a small 
opening. The virtual technique could also be complementary to 
conventional cystoscopy in evaluation of bladder base and anterior 
bladder neck, as well as for post chemotherapy follow-up 
 
9. Sylvain Jaume et  al29 says that  With   an expert  observer 
reading the CT, our algorithm achieves89% sensitivity, 88% specificity, 
48% positive predictive value, and 98% negative predictive value. 
The high negative predictive value makes our software suitable for 
bladder  cancer  screening.  Our  software  accurately  detects  healthy 
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regions, allowing the clinician to focus on the suspicious bladder scans. It 
evaluates  the  bladder  neck,  a  significant  advantage  over  standard 
cystoscopy. 
10. Thiagarajan Nambirajan et al30 done virtual cystoscopy using 
an intravenous contrast  agent  in Eighteen patients with   haematuria .
(92%) of the abnormal lesions at RC were correctly identified at VC. At 
VC, all lesions of >4 mm were identified but only one of three <4 mm 
was seen.  There  were  two false-positive  finding at  VC;  VC correctly 
identified 17 (94%) of 18 abnormal bladders. They   concluded as CT-
based  VC  has  a  high  sensitivity  for  detecting  bladder  lesions  and  is 
comparable with FC; it may have a potential role as a single imaging tool 
for haematuria   
11. Noriyasu Kawai*, et al31Using multi slice CT and a device 
with  16  rows  of  detectors,  examined  five  patients  using  VC  that 
previously  involved catheterization,  termed  'air  VC'  and 16 using  VC 
with the new technique, termed 'IVU VC'. The detection rate of bladder 
tumors by IVU VC was similar to that from air VC; moreover, IVU 
VC overcame two significant disadvantages of air VC. The appearance of 
the water  surface and the need for  catheterization.  They concluded as 
Conventional  cystoscopy is  still  an essential  examination but  this  new 
method  of  IVU VC may  be  ideal  for  preliminary  examination  of  the 
bladder.
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12. Allan  et  al  said  Computed  tomography  and  magnetic 
resonance  imaging  data  sets,  may  now be  used  to  construct  a  virtual 
reality  endoscopic  image.  Thus   allowing  virtual  reality  to  begin  to 
challenge endoscopic evaluation. 
13. Jeong Kon Kim32 et  al   says the agreement  between the 
findings  of  virtual and  conventional  cystoscopy  was  excellent  in  the 
reviewers' identification  of  bladder  lesions  (  =  0.83)  and  detection  of 
abnormal  bladders  (  =  0.89).  The  sensitivity  and specificity of  virtual 
cystoscopy were 95% and 87% for identifying bladder lesions and 95% 
and  93% for  detecting  abnormal  bladders. They  concluded  as  Virtual 
cystoscopy  of  the  contrast  material—filled  bladder is  useful  for  the 
evaluation of the bladder in patients with gross  heamaturia
14. E  M  Merkle,  et  al33 All tumors  of  the  urinary  bladder 
identified at   fibre optic cystoscopy were shown on virtual cystoscopy. 
The best reconstruction results were obtained from data acquired 30 min 
after injection of contrast medium. The ureteric   orifices were not 
visualized at virtual cystoscopy. These data lead us to conclude that, at 
present,  virtual  cystoscopy  has  not  reached  the  quality of  fibre  optic 
examination and remains restricted to use in specific cases, for example 
patients with urethral strictures.
15.  Prarotish   et al  34  The MDCT-derived volumetric data were 
used  to  generate  virtual  cystoscopy  (VC)  images,  which  revealed  a 
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bladder ulcer. The presence of this ulcer was confirmed by conventional 
cystoscopy-guided  biopsy  and  there  was  good  agreement  regarding 
various features of the ulcer, such as the site, size and shape
16. Halil  Arslan,  et  al35 studied  in  Eighteen  patients  with 
different bladder pathologies, which consisted of 11 tumors, 3 diverticula, 
2 trabecular changes and 2 stones, They found    Images in 16 (88%) of 
the 18 virtual cystoscopic examinations were either of excellent or good 
quality. While conventional cystoscopy could not evaluate interior part of 
the  diverticulum,  virtual  CT cystoscopy    could   demonstrate  clearly 
within it..  They   concluded as  Virtual  CT cystoscopy is  a  promising 
technique  to  be used  in  the detection  of  bladder  lesions.  It  should  be 
considered especially at the evaluation of bladder   diverticulum.  
17. WANG Dong  et al35B. The sensitivity of the axial, 3D and CTVC images in detecting 
the bladder tumors were 90.8%, 76.9% and 
95.4% respectively. The dynamic contrast-enhanced axial images could provide excellent 
intramural and extravesical information, and the accuracy in preoperative tumor staging was 
87.7%. 3D and CTVC images were useful for displaying the surface morphology of the tumor 
and the relationship between the tumor and the ureteric orifices, whereas CTVC could depict 
the tumors smaller than 5 mm not seen in axial images. Concluded as The combination of 
axial, MPR, 3D and CTVC images with helical CT can provide comprehensive information 
on bladder tumor.
18. In 1996, Vining et al.14 showed the feasibility of VC in one healthy volunteer and two 
patients with bladder tumor. They filled the bladder with carbon dioxide through a urethral 
catheter and used a volume-rendering algorithm for virtual image processing.
  19. Narumi et al.15 reported their experience of using air as a contrast agent in the bladder 
and used a surface-rendering algorithm, showing 85% of all tumors, 94% of 31 that were 
>1 cm, but only 77% of tumors of <1 cm to be correctly identified.
 20. Fenlon et al.16 reported VC in 13 patients with haematuria and abnormal findings on 
cystoscopy. They used a perspective volume-rendering algorithm and room air as the contrast 
medium. 
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.21. A similar study by Song et al.17 confirmed the technique to be useful for lesions of 
>5 mm, that the optimum evaluation requires adequate bladder distension with the patients 
both supine and prone, and the interpretation of both transverse and virtual images
 22. Kim et al.18 assessed 73 patients with gross haematuria, using 
an  intravenous  contrast  agent  and  a  volume-rendering  algorithm.  The 
sensitivity  and  specificity  of  VC  were  95%  and  87%  for  identifying 
bladder lesions, and 95% and 93% for detecting abnormal bladders.
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MATERIALS AND METHODS
It is a prospective study. There is no deviation in the protocol for 
the evaluation of patients with   hematuria.  29  patients, (6 females, 23 
males)  with   hematuria and a recent   diagnosis   or a history of bladder 
carcinoma referred by the urology department for CT   urography and 
cystoscopy. These patients constituted our study population.
EXCLUSION CRITERIA
Renal failure
Contrast allergy
Pregnancy
Children
Calculus
They  were  subjected  to  USG    and  CT  examinations  were 
performed with a 64 slice   MDCT scanner, (Philips Medical Systems) 
slice  thickness  of  1 mm,  after  an  intravenous  injection  with  80mL of 
Iohexol 300mg  at 3 ml/s. This was followed by a delayed scan, 60 min 
after  injection  with  contrast  medium.  During  the  delay  patients  were 
instructed to move around, with the intention of avoiding sedimentation 
of contrast medium in the bladder. The delayed images were obtained as 
a single breath-hold helical scan, using 120 kV, 250 mA, 1mm thickness 
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and a pitch of 1. These delayed images were used to reconstruct the VC 
image.  
The  data  were  downloaded  to  an  independent  workstation 
(Extended Brilliance  PHILIPS ) equipped with software for interactive 
intra luminal navigation. MPR images 1mm thick at 1-mm intervals were 
obtained  in  the  transverse,  coronal,  and sagittal  planes  .Virtual 
cystoscopic images were obtained with the volume-rendering technique 
and  the  same  software  as  for  the MPR  images.  The  threshold  was 
optimized for each case to obtain complete visualization of the bladder 
wall  with  no  artefacts.  Using  multiplanar  reformation  from  source 
images,  a  central  observation  point  was  defined  in  the  middle  of  the 
lumen of the bladder. The camera for virtual cystoscopy was placed in the 
center of the bladder lumen and thereafter was advanced to each quadrant 
in  turn.  When  a  possible  abnormality  was  discovered,  it  was  fully 
evaluated from various angles.        
The  VC  images  were  reconstructed  and  analysed  by  the 
information for the number, exact location, and other incidental 
abnormalities in the bladder.  The virtual and conventional  cystoscopic 
findings for each patient were documented on separate worksheets.  
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The axial, MPR, and virtual images were prospectively 
interpreted, both separately and in combination, by the number, 
size, location, and morphologic features of the lesions were 
studied. The lesions were characterized as polypoid, sessile, and 
areas of wall thickening. A lesion was characterized as an area of 
wall thickening when there was no associated discrete mass. A 
lesion was considered polypoid if it protruded into the bladder 
lumen and was attached to the bladder wall by a narrow stack. A 
lesion was described as sessile if it was connected to the bladder 
wall by a broad base.  
Detailed forms regarding number, estimated size, and 
location of bladder tumors found at conventional cystoscopy were 
completed by the urologists. The conventional cystoscopies were 
performed with rigid 21F cysto scope (Storz, Germany) with a field 
of view of 30 degrees in all patients under general or local 
anesthesia The findings at MDCT cystoscopy were compared 
with those of conventional cystoscopy
The   following   data are to be collected for analysis:
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1. Clinical presentation
2. Nature of lesion eg. Growth, ulcer
3. Site
4. Size
5. Morphology
6. Number of the tumor
7. Histopathology and grade of the tumor
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TECHNIQUES OF 3D RECONSTRUCTION IN CT 
CYSTOSCOPY
The  volumetric  data  obtained  with  helical  CT  are  computer-
rendered to generate three-dimensional images,  and with commercially 
available software, intra luminal navigation through any hollow viscus  is 
possible. There are two main techniques for the reconstruction of virtual 
image.  One  of  them  is  volume  rendering  and  the  other  is  surface-
rendering  algorithm.  Of  the  different  three-dimensional  rendering 
techniques available,   the perspective volume rendering provides more 
information because the entire data set is incorporated. I used a volume 
rendering algorithm in this study
3D Imaging
The  process  of  3D  imaging  began  with  image  acquisition 
protocols,  which  were  optimized  for  subsequent  post-processing.  To 
withhold positive oral and rectal contrast agents to obtain satisfactory 3D 
CT  images.  This  is  particularly  important  CT  urography  when  3D 
reconstruction is planned.  Optimum contrast  volume, rate of  injection, 
and timing of the scan at the peak concentration are pre-requisites for 
most 3D angiography applications. Only good source axial image data 
can provide reasonable quality 3D reconstruction. It is therefore critical to 
s
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obtain thin, overlapping sections of the region of interest with minimum 
motion artifacts.
Surface rendering (shaded surface display, SSD) is a surface-fitting 
algorithm that creates triangle-based iso surfaces within 3D space. For 
surface rendering, the user specifies a threshold attenuation value close to 
the  center  of  the  signal  difference  between  the  brightest  pixel  found 
within the object of interest and the signal in the surrounding structures. 
Then,  the  surface-rendering  algorithm loops  on  successive  slices  and 
determines whether  its  corner values straddle the threshold values and 
chosen to generate surface rendering datasets.
Volume rendering (multiplanar volume rendering, MPVR) is the 
visualization and manipulation of objects represented as sampled data in 
three or more dimensions. The technique interpolates the entire data set 
rather  than editing a  single  scan  to  generate  3D images  directly  from 
scanned volume data. 
The maximum intensity  projection (MIP)  technique displays the 
pixels  of  greatest  intensity  along a predefined axis of the image.  It  is 
useful  for  the  depiction  of  anatomy  when  there  is  a  large  difference 
between attenuation values (Hounsfield value, HU) pacified by contrast 
agent, and the surrounding tissues.
a
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Navigation Models 
Planned Navigation (“Autopilot“)   Predefined navigation   for automatic 
movement along the traversed path with planned protocols .It has 
Specification of a camera path. Camera is more or less fixed to that path.
Manual/free Navigation
Interactive navigation - For mouse controlled movement
Guided Navigation: Combines flexibility and guidance. Interactive and 
intuitive. Camera dives through scene like submarine
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OBSERVATION AND RESULTS
CT scanning was well tolerated by 29patients.  Male 23, Female   6 
including one case post cystectomy with ureteric diversion
No  complication  occurred.   Images  in  100%of  the  29  virtual 
cystoscopic  (vc)  examinations  were  of  good  quality  with  adequate 
bladder  distention.  60  lesions  were  seen  in  virtual  cystoscopy  in  29 
patients. On conventional cystoscopy 60 lesions were found in 27patients. 
55   lesions  of  vc  were found to be tumor on conventional cystoscopy 
and biopsy. Out of five lesion   which are  not  tumors proved to benign 
lesions. Out of five   3 were flat lesions found to be  trabeculations  on 
conventional cystoscopy . Rest  two were sessile lesions one was grade 
3mucosal  changes,  one  was  enlarged  lateral  lobe  of  the  prostate   on 
conventional  cystoscopy.  The   masses ranged from1. 7mmto 7.4cm.45 
Out of   60   were polypoid lesions. 10 were sessile lesion.5 were flat 
lesions  in  vc.  All  these  tumors  had  been  described  by  the  virtual 
cystoscopy with nearly similar findings in size localization. However the 
lobulated   morphologic characteristics of a small polypoid lesion were 
better depicted on the virtual image.  There   is no false positive regarding 
for    lesion  identification  and  polypoidal  lesions    for  correlation  of 
tumor .  
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vc Conventional cystoscopy
Pedunculated 45 44
Sessile 10 7
Flat 5 4
Total no  lesion 60 60
Adjacent irregularity 15 13
Ureter  involvement 2 2
Uvj involvement 2 2
Adjacent cis 0 5
Involvement of pelvis 0
Single lesion   was found in 9 patients in Conventional cystoscopy 
and Virtual   cystoscopy.  Patients with More than one lesion was found 
in 13 patients.  Patients  with multiple  lesions were 2.
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HISTOLOGICAL DIAGNOSIS 
Lowgrade muscle non invasive TCC in 13 cases (52% ).
Highgrade muscle invasive TCC in 8 cases (32%) 
Both high and low grade -2  (8%) 
TCC 92% 
         Adeno  carcinoma  1 (4%) 
Mesenchymal tumor  1 (4%)
(
TREATMENT FOLLOWUP
TURBT   done in 14  patients. 
RADICAL CYSTECTOMY was done in 4 patients.
PARTIAL   CYSTECTOMY   in 2 cases. 
Nephro uretrectomy- in 2 cases .
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RT&chemo  was given for 2cases. 
No intervention   in 5cases
STATISTICAL ANALYSIS
The clinical trials were described according to their age and sex by 
the  statistical  mean  and  standard  derivatives.  The  difference  of  age 
between  the  sexes  was  interpreted  by  the  student`s  `t`  test.  The 
morphology of the study   sub sects in terms of number of lesions found 
by conventional  cystoscopy and virtual  cystoscopy were analyzed and 
interpreted by students paired `t` test. The positivity and negativity for 
morphology and  sites of conventional cystoscopy and virtual cystoscopy 
studies  were  studied  according  to  the  presence  and  not  presence  by 
sensitivity  and  specificity  tests.  The  above  statistical  procedures  were 
performed by the statistical package namely S.P.S.S (13.O) at 5% level of 
significance (p= 0.05).
7
The clients of the study were described according to their age and 
sex with comparison 
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Age group
(years)
male Female Total
no % no % no %
40-49 2 9.5 3 50.0 5 18.5
50-59 8 38.1 3 50.0 11 40.7
60-69 8 38.1 - - 8 29.6
70-79 2 9.5 - - 2 7.4
80-89 1 4.8 - - 1 3.8
Total 21 100 6 100 27 100
 
      
The above table -1 evaluates the clients according to their age and 
sex distribution. The mean age of the male was 60.3+/-9.1 and the female 
was50.3+/- 4.3. The difference of age 10 years between the sexes was 
statistically significant (p<0.05).
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 Range 50-80YRS 45-57yrs 45-80yrs
Mean 60.3 50.3 58.1
S.D 9.1 4.3 9.2
`t` 2.585
Significance P<0.05
The  mean  age of the total study   subsets   was 58.1+/- 9.2 years. 
The male   clients  age was ranging in between 50- 80 years.  The female 
ages were ranging in between 45-57.The total age was in between the 
years   45- 80.
.
COMPARISON  BY  MEANS  OF  TOTAL  LESIONS  BY 
MORPHOLOGY
The lesions morphology diagnosed and screened by conventional 
cystoscopy and virtual cystoscopy of the study    subsets were analyzed 
and interpreted as follows.
Cystoscopy morphology M.D `t` d.f significance
mean S,D 0.2 0.811 26 P>0.05
CC 2.0 1.7
VC 2.2 2.0
 
Table-2 Number of lesion morphology by conventional and virtual 
cystoscopy-comparison.
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The  above  table-2  shows  that  the  mean  morphology  lesions  of 
conventional  cystoscopy  was  2.0 +/-  1.7  and the same of  the virtual 
cystoscopy  was 2.2 +/-2.0 The morphology lesions which were more in 
number by virtual cystoscopy was not  significant  statistically(p>0.05) 
Sessile 
investigated by
conventional %
Sig
nifi
can
ce
%
sign
ific
anc
e
P
r
e
s
e
n
t
N
o
t 
p
r
e
s
e
n
t
Tota
l
Se
ns
iti
vit
y
Sp
ec
ifi
cit
y
ppv npv
Virtu
al 
cysto
scopy
Present 5 4 9
83.3 81.0
P 
>0.05
55.6 94.4
P 
<0.05N.P 1 17 18
total 6 21 27
 
  
In the above the table-3 the presence of sessile  lesion was given by 
the  diagnosis  and  screening  by  conventional  and  virtual  cystoscopy 
respectively.  The  sensitivity    and specificity    were  83.3% and 81% 
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respectively.  The    difference  was  not  statistically    significant.(p 
>0.05).That means with respect to sensitivity and specificity both were 
same.  But  there  was  a  significant  difference  with  respect  to  positive 
predictive value and negative predictive   value. This  difference  was 
attributed  to the low prevalence of positivity in both  investigations.
TABLE - 4 COMPARISON OF PEDUNCULATED LESIONS
Pedunculated
conventional %
signif
icanc
e
% significance
P NP
t
o
t
a
l
se
ns
iti
vit
y
sp
ec
ifi
cit
y ppv npv
Virt
ual 
cyst
osc
opy
P 19 0 19
86. 100 p>0.05 100 62.5 P<0.05
NP 3 5 8
total 22 5 27
In the above table -4 also the sensitivity and specificity were not 
statistically  significant  (p  >0.05).  But  the  positive   predictive 
value(  100%)  was  significantly  greater  than  the  negative   predicative 
value(62.5%).This was attributed  to the high prevalence of positive(p > 
0.05).
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TABLE-5 COMPAISION OF FLAT  LESIONS
Flat lesion 
investigated by
conventional %
signific
ance
%
sign
ifica
nce
p
r
e
s
e
n
t
N
ot 
pr
es
en
t
t
o
t
a
l
se
ns
iti
vit
y
sp
ec
ifi
cit
y
ppv npv
virtual
Present 3 2 5
75.0 91.3 p>0.05 60.0 95.4
P 
>0.05
NP 1 21 22
total 4 23 27
 
The  above  table-5  explains  the  flat  lesions  presented  by  both 
investigation  and  found  that  there  were  no  significant  differences 
observed either in between sensitivity and specificity in between positive 
predictive value and negative predictive value.
With respective to flat  lesion detected by both instruments were 
the same (p >0.05)
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TABLE  -  6  COMPARISION  OF  LESIONS  PRESENT  ON  THE 
DOME.
The presence of the positive lesions on the   dome was shown in 
the below table-6. Clearly shows that 100%o f presentation of positive 
cases by both investigations    since the sensitivity and specificity were 
equal and the   positive predictive value and negative predictive value 
were also equal. (100%).
Dome lesion 
investigated by
conventional percentage sign
ifica
nce
percentage sign
ifica
nce
p
r
e
s
e
n
t
N
ot 
pr
es
en
t
t
o
t
a
l
se
ns
iti
vit
y
sp
ec
ifi
cit
y
ppv npv
virtual Present 7 0 7
100.0 100.0 - 100 100 -
Not 
present
0 20 20
total 7 20 27
.
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TABLE-7  COMPARISON OF  PRESENCEOF  LESION  ON THE 
BASE 
investigated 
by (lesion on 
base)
conventional percentage signif
icanc
e
percentag
e
signific
ancep
r
e
s
e
n
t
N
ot 
p
re
se
nt
t
o
t
a
l
se
ns
iti
vi
ty
sp
ec
ifi
ci
ty
ppv npv
virtua
l
Present 5 0 5 100.
0
100.
0
- 100 100 -
Not 
present
0 22 22
total 5 22 27
The comparison shown in the table   -7  illustrate  that  there  was 
equal presence of positivity in both instruments (100%). 
TABLE-8. COMPARISON OF ANTERIOR SURFACE
anterior 
surface 
investigated by
conventional percentage signifi
cance
percentage signif
icanc
e
p
r
e
s
e
n
t
N
ot 
pr
es
en
t
t
o
t
a
l
se
ns
iti
vi
ty
sp
ec
ifi
cit
y ppv npv
virtua
l
Present 7 1 8
87.5 94.7 p>0.05 87.5 94.7 p>0.05N.P 1 18 19
total 8 19 27
Positive predictive value (PPV)
Negative predictive value (NPV)
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 In the above table analysis showed in the table-8.States that the 
sensitivity and specificity were differed not significantly (p >0.05) 
similarly   the   PPV  and  NPV  were  also  not  differed  significantly 
(p>0.05).
TABLE-9 COMPARISON OF POSTERIOR SURFACE
posterior lesion 
investigated by
conventional percentage
signifi
cance
percentage signif
icanc
e
p
r
e
s
e
n
t
N
ot 
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en
t
t
o
t
a
l
se
ns
iti
vi
ty
sp
ec
ifi
cit
y ppv npv
virtua
l
Present 4 1 5
80.0 95.5 p>0.05 80.0 95.5 p>0.05N.P 1 21 22
total 5 22 27
The above  comparison shown in the above table -9 shows that 
there  was  no  significant   difference  in  between  the  sensitivity  and 
specificity   as well as positive predictive value and negative predictive 
value . It reveals that both were equal in predicting positive cases.
TABLE -10. COMPARISON OF RT LATERAL WALL.
Rt lateral  wall 
lesion 
investigated by
conventional percentage
signifi
cance
percentage
Significa
nce
p
r
e
s
e
n
t
N
ot 
pr
es
en
t
t
o
t
a
l
se
ns
iti
vit
y
sp
ec
ifi
cit
y ppv npv
virtual
Present 18 0 18
100.
0
100.
0 -
100.
0
100.
0 -N.P 0 9 9
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total 18 9 27
The above table -10, the conventional and virtual cysto scopies had 
shows   100% similarity in predicting the positive   and negative and also 
in respect of sensitivity and specificity
t
TABLE -11. COMPARISON   OF   LESION ON LEFT LATERAL 
WALL
Lt lateral  wall 
lesion 
investigated by
conventional percentage
signifi
cance
percentage
signif
icanc
e
p
r
e
s
e
n
t
N
ot 
pr
es
en
t
t
o
t
a
l
se
ns
iti
vi
ty
sp
ec
ifi
cit
y
ppv npv
virtua
l
Present 7 0 7
100.
0
100.
0
-
100.
0
100.
0
-
N.P 0 20 20
total 7 20 27
The  above  table  -11  explains  the  sensitivity  and  specificity  of 
positive   presentation   in the    lateral wall by the two investigations. 
Both investigation were predicting 100% positive   and 100  %negative. It 
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reveals that the there was no difference between the   instruments, since 
the two tests had screened 100% in all respect.
FINDINGS
The female were 10 years younger than the males with respect to 
the    disease. Since  the mean age of female 50.3 +_ 4.3 was significantly 
earlier than the mean age of males 60.3 + 9.1.( p > 0.05).
a
The  virtual    cystoscopy  had  identified  an  average  of  2  +  2.0 
morphology  lesions  and the conventional  cystoscopy  had identified 
little bit less than an average lesions 1.0+ 1.7. But the difference was not 
significant.
From the analysis   and   interpretation of morphology    namely 
sessile,  pedunculated,  flat,  and  wall   thickening   the  sensitivity  and 
specificity of the tests were not  statistically significant ( p > 0.05). It 
proved that both   were equal in respect of sensitivity and specificity. But 
there were significant difference in respective of their positive   predictive 
and   negative predictive values in respect of   sessile  and   pedunculated. 
That  difference   were    attributed    to  low    prevalence  and  high 
prevalence of positive cases of respective   morphology .  The presence of 
positives  on  the    six  sites    lay  the  two  investigations  namely 
conventional  and  virtual    cystoscopies  were  not   statistically  and 
significant in respect of sensitivity and specificity  and positive predictive 
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value and negative  predictive value. Both were   equal   in identifying the 
positive cases.
From the above analysis and   interpretation virtual cystoscopy   is 
equal  to  the conventional  cystocopy  in identifying lesions.
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DISCUSSION
We were able to identify all the lesions which were identified by conventional cystoscopy. 
No sub centimeter lesion was missed comparing to previous studies due to MDCT thin 
section imaging 
The   referral   study    was conducted in 18 patients sensitivity of VC (virtual cystoscopy) 
was 92% for detecting all lesions, and 100% for lesions of >4 mm and 94% for abnormal 
bladders. VC is not sufficiently sensitive to detect tumors of <4 mm because of limited 
resolution with a slice acquisition of 3 mm with   helical CT. In  my  study using 64 MDCT 
CONTRAST   with 1mm slice   no sub  cm lesion   was missed   and the smallest  was1.7 
mm.  sensitivity of VC was 100% for detecting all lesions, and 100% for abnormal bladders
 In the referral study   Of the total of 36 abnormal lesions seen at RC, 33 (92%) were correctly 
identified at VC. There were two false-positive identifications of lesions at VC. Of the 18 
abnormal bladders on RC, VC correctly detected 17 (94%). Four  were <4 mm, and three of 
these were missed on VC, with one of 3 mm missed on FC and correctly located by VC. Thus 
all lesions of >4 mm were detected by VC and only one of four <4 mm.  In my study   from 
25 abnormal bladder   60    lesions   were identified in VC     60 lesions identified in 
conventional .no lesion was missed .The   smallest is1.7 mm.
b
Morphological   correlation   with tumor   histology    100% positive  predictive  value  and 
sensitivity  for polypoidal lesions.    2 Sessile lesion   which were not tumor   one   was 
enlarged lateral lobe of prostate  another was grade 3 mucosal change. The sensitivity   and 
specificity  were 83.3% and 81% respectively   for sessile lesion   in diagnosis  of tumor by 
conventional and virtual cystoscopy   respectively. For flat lesion  sensitivity 
75.,specificity91.3  positive  predictive  value(60 negative  predictive  value 95.4% .
. Of the 33 lesions seen on VC, the locations of all were correctly described at VC when 
compared with RC, in the referral study.  And also   in my study the locations of all were 
correctly described at VC when compared with RC.
In  the referral study  the histology results were available for all patients and all had TCC 
except one who had re-growth of the prostate mimicking a bladder tumor. One patient had 
carcinoma in situ (CIS) in addition to G3pT1 tumor.  In my study Lowgrade muscle non 
invasive TCC in 13 cases (52%). Highgrade muscle invasive TCC in 8 cases (32%) Both high 
and low grade -2 (8%) TCC 92% adeno carcinoma 1 (4%) ,mesenchymal tumor 1.In my study 
one case was found to invasive growth from sigmoid   proved as Adeno ca. 
VC the lesions can be easily related to anatomy outside the bladder.
%
 One   case which was sent for CECT abdomen for haematuria .The axial images revealed 
bladder wall thickening and peri vesical infiltration.  With virtual cystoscopy it was clearly 
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established the extra luminal origin of lesion from adjacent sigmoid growth infiltrating in to 
the bladder lumen as small polypoidal and a small flat lesion.  
Another   case   which was referred from outside our hospital after inconclusive cystoscopy 
after biopsy from the lesion due to profuse bleeding.USG   findings bladder wall thickening 
and large mass .The axial images were interpreted as tumor   with possible hematoma with 
help of virtual images we are able to say that leiomyomatous polyp from its cystoscopic 
appearance with normal looking  mucosa  which  was postoperatively identified as solitary 
fibrous tumor. We    were able to study about the pelvi calyceal system in all the cases   which 
was not possible with conventional cystoscopy .
one case after   urinary diversion done    with axial images the possible pathology at diversion 
site and possible metastatic Adeno ca could not be ruled out. With   virtual images we were 
able fly through the renal pelvis to ileal loops for long segment positively rule   out lesions. 
With   virtual images we were able to say with confidence about intra luminal  pathology 
without  asking for cystoscopic correlation. Virtual  CT cystoscopy   superior to demonstrate 
the interior part of the diverticulum. 
4
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CONCLUSION
In conclusion, virtual CT cystoscopy is a promising technique for tumor and some other 
bladder lesions, such as diverticula. This minimally invasive method can be of value for 
screening, primary diagnosis and surveillance of bladder lesions.  Virtual CT cystoscopy may 
be done as   part of routine when ct urography is being done and it also may be done when 
conventional cystoscopy is contraindicated or restricted in feasibility and interpretation or 
there is risk of hemorrhage, perforation, or pain especially in young patients.  It identifies 
abnormalities in the bladder as accurately as FC and is feasible in situations where FC could 
not be used bladder debris obscuring vision and when the patient could not tolerate the 
procedure.
VC does not identify CIS. This can be seen as a major disadvantage of VC against FC. The 
one false-negative result was a result of the difficulty is assessing the mucosa in the presence 
of gross trabeculation.. The advantages of VC include being a totally noninvasive screening 
test for haematuria, evaluating both upper and lower urinary tracts, replacing several with one 
test it is possible to view the lesion from many directions and accurately locate and measure 
it. The data are stored electronically and can be repeated at any time and by different people 
in different places. VC allows simultaneous staging of the bladder tumor. It 
is possible now to create virtual ureteroscopic images from the same datasets and the 
abdominal organs are simultaneously screened. The processing time has decreased with new 
workstations, currently taking only a few minutes. The objective of the test is simply to define 
the patient groups who need further evaluation with RC. 
The disadvantages include the cost, radiation exposure .The urethra is visualized poorly and it 
is not possible to obtain histology.   
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